Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Kiewe · SciRah

Researcher profile · Semantic Scholar

P. Kiewe

Share profile

P. Kiewe — researcher profile on SciRah

h-index: 20
Works: 72
Citations: 1,703

Most-cited papers

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.
U. Platzbecker, U. Germing, K. Götze, P. Kiewe +9 more
2017The Lancet Oncology287 citations
Semantic Scholar
Phase I Trial of the Trifunctional Anti-HER2 × Anti-CD3 Antibody Ertumaxomab in Metastatic Breast Cancer
P. Kiewe, S. Hasmüller, S. Kahlert, M. Heinrigs +8 more
2006Clinical Cancer Research160 citations
Semantic Scholar
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.
A. Korfel, U. Schlegel, U. Herrlinger, M. Dreyling +8 more
2016Journal of Clinical Oncology122 citations Open access
Semantic Scholar
CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
L. Fischer, A. Korfel, Sebastian Pfeiffer, P. Kiewe +4 more
2009Clinical Cancer Research114 citations Open access
Semantic Scholar
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer
P. Kiewe, S. Hasmüller, S. Kahlert, M. Heinrigs +6 more
200581 citations
Semantic Scholar
Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial
P. Roth, P. Martus, P. Kiewe, R. Möhle +7 more
2012Neurology79 citations Open access
Semantic Scholar
Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes.
K. Jahnke, M. Hummel, A. Korfel, T. Burmeister +5 more
2006Journal of Clinical Oncology79 citations
Semantic Scholar
Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort.
P. Kiewe, L. Fischer, P. Martus, E. Thiel +1 more
2010Neuro-Oncology66 citations Open access
Semantic Scholar
Ertumaxomab: a trifunctional antibody for breast cancer treatment
P. Kiewe, E. Thiel
2008Expert Opinion on Investigational Drugs54 citations
Semantic Scholar
Progressive Multifocal Leukoencephalopathy with Detection of JC Virus in a Patient with Chronic Lymphocytic Leukemia Parallel to Onset of Fludarabine Therapy
P. Kiewe, S. Seyfert, S. Körper, K. Rieger +2 more
2003Leukemia and Lymphoma53 citations
Semantic Scholar
First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.
S. Maza, P. Kiewe, D. Munz, A. Korfel +3 more
2009Neuro-Oncology50 citations Open access
Semantic Scholar
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
Peter Schmid, Dagmar Kühnhardt, P. Kiewe, Silvia Lehenbauer-Dehm +11 more
2008Annals of Oncology49 citations Open access
Semantic Scholar
Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3): Results of a Phase 1/2 Study
M. Sebastian, P. Kiewe, W. Schuette, Daniel Brust +13 more
2009Journal of immunotherapy48 citations
Semantic Scholar
Prediction of qualitative outcome of oligonucleotide microarray hybridization by measurement of RNA integrity using the 2100 Bioanalyzer™ capillary electrophoresis system
P. Kiewe, Saskia Gueller, M. Komor, A. Stroux +2 more
2009Annals of Hematology47 citations Open access
Semantic Scholar
A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors
P. Schmid, P. Kiewe, D. Kuehnhardt, A. Korfel +5 more
200544 citations
Semantic Scholar
Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma
S. Maza, R. Buchert, W. Brenner, D. Munz +3 more
2013Radiology and Oncology41 citations Open access
Semantic Scholar
Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study
U. Platzbecker, K. Götze, P. Kiewe, U. Germing +15 more
2022Journal of Clinical Oncology29 citations Open access
Semantic Scholar
Efficacy and Pharmacologic Data of Second-Generation Tyrosine Kinase Inhibitor Nilotinib in BCR-ABL-Positive Leukemia Patients with Central Nervous System Relapse after Allogeneic Stem Cell Transplantation
M. Reinwald, E. Schleyer, P. Kiewe, I. Blau +9 more
2014BioMed Research International29 citations Open access
Semantic Scholar
Luspatercept Treatment Leads to Long Term Increases in Hemoglobin and Reductions in Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from the Phase 2 PACE-MDS Extension Study
A. Giagounidis, U. Platzbecker, U. Germing, K. Götze +12 more
201528 citations
Semantic Scholar
Systemic high-dose methotrexate plus ifosfamide is highly effective for central nervous system (CNS) involvement of lymphoma
L. Fischer, A. Korfel, P. Kiewe, M. Neumann +2 more
2009Annals of Hematology21 citations Open access
Semantic Scholar
ACE-536 Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from a Phase 2 Study
U. Platzbecker, U. Germing, A. Giagounidis, K. Goetze +11 more
201420 citations
Semantic Scholar
Primary central nervous system lymphoma
P. Kiewe, L. Fischer, P. Martus, E. Thiel +1 more
2008Cancer20 citations
Semantic Scholar
Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study
U. Platzbecker, U. Germing, K. Götze, P. Kiewe +11 more
201616 citations
Semantic Scholar
Current treatment of mantle cell lymphoma: results of a national survey and consensus meeting
M. Witzens-Harig, G. Hess, Johannes Atta, M. Zaiss +13 more
2012Annals of Hematology13 citations
Semantic Scholar
HLA-A2 expression, stage, and survival in colorectal cancer
P. Kiewe, V. Mansmann, C. Scheibenbogen, H. Buhr +2 more
2008International Journal of Colorectal Disease12 citations
Semantic Scholar
Reversible Ageusia after Chemotherapy with Pegylated Liposomal Doxorubicin
P. Kiewe, S. Jovanovic, E. Thiel, A. Korfel
2004The Annals of Pharmacotherapy12 citations
Semantic Scholar
Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma.
P. Kiewe, N. Bechrakis, A. Schmittel, P. Ruf +3 more
2006Annals of Oncology11 citations Open access
Semantic Scholar
Topotecan and ifosfamide systemic chemotherapy for CNS involvement of solid tumors
P. Kiewe, E. Thiel, M. Reinwald, A. Korfel
2011Journal of Neuro-Oncology10 citations
Semantic Scholar
Penetration of ifosfamide and its active metabolite 4-OH-ifosfamide into cerebrospinal fluid of patients with CNS malignancies
P. Kiewe, M. Neumann, T. Wagner, S. Seyfert +3 more
2010Cancer Chemotherapy and Pharmacology10 citations
Semantic Scholar
Unusual sites of Hodgkin's lymphoma: CASE 3. Cholemic nephrosis in Hodgkin's lymphoma with liver involvement.
P. Kiewe, A. Korfel, C. Loddenkemper, L. Fischer +5 more
2004Journal of Clinical Oncology10 citations Open access
Semantic Scholar
Lymphozytäre Myokarditis unter Nivolumabtherapie bei metastasiertem klarzelligen Nierenzellkarzinom
R. Sauer, P. Kiewe, M. Desole, M. Schuler +3 more
2017Der Pathologe9 citations
Semantic Scholar
53 LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
U. Platzbecker, U. Germing, A. Giagounidis, K. Götze +12 more
20158 citations
Semantic Scholar
Mammalian‐target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D‐MDS)
M. Wermke, C. Schuster, F. Nolte, H. Al-Ali +14 more
2016British Journal of Haematology7 citations Open access
Semantic Scholar
High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.
P. Kiewe, C. Loddenkemper, I. Anagnostopoulos, M. Reinwald +2 more
2007Neuro-Oncology7 citations Open access
Semantic Scholar
Biomarkers of Ineffective Erythropoiesis Predict Response to Luspatercept in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Final Results from the Phase 2 PACE-MDS Study
U. Platzbecker, U. Germing, A. Giagounidis, K. Götze +12 more
20156 citations
Semantic Scholar
LUSPATERCEPT INCREASES HEMOGLOBIN AND REDUCES TRANSFUSION BURDEN IN PATIENTS WITH LOW OR INTERMEDIATE-1 RISK MYELODYSPLASTIC SYNDROMES (MDS): PRELIMINARY RESULTS FROM THE PHASE 2 PACE-MDS STUDY
U. Platzbecker, U. Germing, A. Giagounidis, K. Goetze +12 more
20155 citations
Semantic Scholar
Antiviral cellular immunity in colorectal cancer patients.
P. Kiewe, Susanne Wojtke, E. Thiel, D. Nagorsen
2009Human Immunology5 citations
Semantic Scholar
Altered treatment of chronic lymphocytic leukemia in Germany during the last decade
A. Zoellner, T. Höhler, S. Fries, A. Böhme +3 more
2016Annals of Hematology4 citations
Semantic Scholar
Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin’s lymphoma
P. Kiewe, E. Thiel
2010Annals of Hematology4 citations Open access
Semantic Scholar
Isolated B-cell lymphoproliferative disorder at the dura mater with B-cell chronic lymphocytic leukemia immunophenotype.
P. Kiewe, F. Dallenbach, L. Fischer, S. Hoecht +3 more
2007Clinical Lymphoma & Myeloma4 citations
Semantic Scholar
Extensive leukemic kidney infiltration with membranoproliferative glomerulonephritis in a patient with B-cell chronic lymphocytic leukemia
P. Kiewe, Martin Tepel, C. Loddenkemper, M. Grünbaum +3 more
2007Annals of Hematology4 citations
Semantic Scholar
Phase I trial of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
K. Possinger, W. Schippinger, P. Kiewe, W. Lange +7 more
20054 citations
Semantic Scholar
Combination Treatment of Venetoclax and Hypomethylating Agents (HMA) or Low-Dose Cytarabine (LDAC) for Patients with Acute Myeloid Leukemia (AML) - Real-World Data from Two German Academic Centers
L. Schmalbrock, K. Braitsch, P. Jung, I. Bumeder +8 more
2021Blood2 citations Open access
Semantic Scholar
Diffuse Leukoencephalopathy and Brain Edema: Unusual Presentations of CNS Relapse of Acute Myeloid Leukemia
M. Schumann, P. Kiewe, S. Hartlieb, M. Neumann +4 more
2010Journal of Neuroimaging2 citations
Semantic Scholar
Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines: Final results of a phase I/II study
P. Schmid, A. Regierer, P. Kiewe, W. Schippinger +7 more
20072 citations
Semantic Scholar
CXCL12 and CXCL13 Levels in Cerebrospinal Fluid (CSF) of Patients with CNS Lymphoma.
L. Fischer, P. Kiewe, Sebastian Pfeiffer, H. Cakiroglu +1 more
20072 citations
Semantic Scholar
Penetration of Yttrium-90-Labeled Ibritumomab Tiuxetan (Zevalin™) into Primary CNS Lymphoma.
P. Kiewe, A. Korfel, S. Maza, K. Jahnke +2 more
20062 citations
Semantic Scholar
Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: “Real World” Data From Germany
K. Braitsch, L. Schmalbrock, P. Jung, I. Bumeder +10 more
2022HemaSphere1 citations Open access
Semantic Scholar
Intrasplenic Pancreatic Pseudocyst after Chemoradiation of a Pancreatic Adenocarcinoma Mimicking Progressive Disease: A Case Report and Review of the Literature
T. Benter, Oliver Roehr, L. Moser, P. Kiewe +3 more
2019Case Reports in Oncological Medicine1 citations Open access
Semantic Scholar
Mutational Profile and Analysis of Lower-Risk Myelodysplastic Syndromes (MDS) Patients Treated with Luspatercept: Phase 2 PACE-MDS Study
U. Platzbecker, P. Kiewe, U. Germing, K. Götze +13 more
20171 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Thiel×30
Invite
E. Thiel — researcher profile on SciRah
A. Korfel×21
Invite
A. Korfel — researcher profile on SciRah
U. Platzbecker×10
Invite
U. Platzbecker — researcher profile on SciRah
U. Germing×9
Invite
U. Germing — researcher profile on SciRah

×9

Invite

K. Mayer — researcher profile on SciRah

Invite

M. Radsak — researcher profile on SciRah

Invite

T. Wolff — researcher profile on SciRah

Invite

K. Attie — researcher profile on SciRah

A. Giagounidis×9

Invite

A. Giagounidis — researcher profile on SciRah

Invite

K. Götze — researcher profile on SciRah

Invite

M. Sherman — researcher profile on SciRah

Xiaosha Zhang×7

Invite

Xiaosha Zhang — researcher profile on SciRah